首页 | 本学科首页   官方微博 | 高级检索  
     

44例儿童神经母细胞瘤临床分析
引用本文:朱呈光,贺湘玲,汤止戈,陈可可,邹润英,田鑫,游亚兰. 44例儿童神经母细胞瘤临床分析[J]. 中国当代儿科杂志, 2020, 22(11): 1193-1197. DOI: 10.7499/j.issn.1008-8830.2005053
作者姓名:朱呈光  贺湘玲  汤止戈  陈可可  邹润英  田鑫  游亚兰
作者单位:朱呈光, 贺湘玲, 汤止戈, 陈可可, 邹润英, 田鑫, 游亚兰
基金项目:

儿童实体肿瘤精准诊疗的基础与临床研究-湖南省科技厅重点研发项目(2018SK21216)。

摘    要:
目的 分析儿童神经母细胞瘤(NB)的临床特点及影响生存率的因素,为进一步优化儿童NB诊治方案提供依据。方法 以2016年4月至2020年2月收治的44例NB患儿为研究对象,回顾性分析患儿的临床资料及随访资料。结果 44例NB患儿初次就诊常见临床症状依次为发热(10/44,23%)、发现肿块(9/44,20%)、腹痛(8/44,18%)、咳嗽(7/44,16%)、面色苍白(3/44,7%)、跛行(2/44,5%)及活动异常(2/44,5%)。根据INSS分期,Ⅰ期2例(4%)、Ⅱ期5例(11%)、Ⅲ期5例(11%)、Ⅳ期32例(73%)。44例患儿平均随访时间为(15.3±1.5)个月,复发率为20%,总生存率为82%,其中无事件生存29例(66%),带瘤生存7例(16%)。病理类型为NB、血清神经元特异性烯醇化酶增高可降低NB患儿的总生存率(P < 0.05)。结论 NB患儿初诊临床症状无明显特异性,多以发热、腹痛、发现肿块最常见;初诊晚期患儿占比高;病理分型为NB、血清神经元特异性烯醇化酶增高可能与NB患儿总生存率降低有关。

关 键 词:神经母细胞瘤  临床分析  儿童  
收稿时间:2020-05-09
修稿时间:2020-08-20

Clinical features of neuroblastoma: an analysis of 44 children
ZHU Cheng-Guang,HE Xiang-Ling,TANG Zhi-Ge,CHEN Ke-Ke,ZOU Run-Ying,TIAN Xin,YOU Ya-Lan. Clinical features of neuroblastoma: an analysis of 44 children[J]. Chinese journal of contemporary pediatrics, 2020, 22(11): 1193-1197. DOI: 10.7499/j.issn.1008-8830.2005053
Authors:ZHU Cheng-Guang  HE Xiang-Ling  TANG Zhi-Ge  CHEN Ke-Ke  ZOU Run-Ying  TIAN Xin  YOU Ya-Lan
Affiliation:ZHU Cheng-Guang, HE Xiang-Ling, TANG Zhi-Ge, CHEN Ke-Ke, ZOU Run-Ying, TIAN Xin, YOU Ya-Lan
Abstract:

Objective To study the clinical features of neuroblastoma (NB) and the factors influencing survival rate. Methods A total of 44 children with NB who were admitted from April 2016 to February 2020 were enrolled as research subjects. A retrospective analysis was performed on their medical data and follow-up data. Results The common clinical symptoms of these 44 children were fever (10/44, 23%), mass (9/44, 20%), abdominal pain (8/44, 18%), cough (7/44, 16%), pale complexion (3/44, 7%), claudication (2/44, 5%), and abnormal activity (2/44, 5%). According to the INSS stage, 2 children (4%) had stage I NB, 5 children (11%) had stage II NB, 5 children (11%) had stage III NB, and 32 children (73%) had stage IV NB. The mean follow-up time was (15.3±1.5) months, with a recurrence rate of 20% and an overall survival rate of 82%. Among the 44 children, 29 (66%) achieved event-free survival and 7 (16%) had survival with tumor. The univariate analysis showed that a pathological type of NB and an increase in serum neuron-specific enolase (NSE) decreased the overall survival rate of children with NB (P < 0.05). Conclusions The clinical symptoms of children with NB are not specific at the first visit. Fever, abdominal pain, and mass are common symptoms, and there is a high proportion of children in the advanced stage. The pathological type of NB and an increase in serum NSE may be associated with a reduction in the overall survival rate of children with NB.

Keywords:

Neuroblastoma|Clinical analysis|Child

点击此处可从《中国当代儿科杂志》浏览原始摘要信息
点击此处可从《中国当代儿科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号